<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04421092</url>
  </required_header>
  <id_info>
    <org_study_id>00096384</org_study_id>
    <nct_id>NCT04421092</nct_id>
  </id_info>
  <brief_title>Efficacy of SLN Block for Chronic Cough</brief_title>
  <official_title>Efficacy of Superior Laryngeal Nerve Block for Chronic Cough</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a research study to find out if superior laryngeal nerve blocks are an effective way
      to reduce cough when compared to placebo (a substance without any medical value). Eligibility
      for the study include the following: age &gt;18, cough history suggestive that the nerve to the
      voice box is overactive, non-smoker, Patients will be followed over time and assigned to
      either the treatment or placebo group at random. The treatment would be four superior
      laryngeal nerve blocks and the placebo would be four saline injections (the inactive
      substance). Study team will measure if the injection improved cough and ask patients to keep
      a log of symptoms and fill out questionnaires at each visit. After the four injections,
      patients will follow up in 3 months to see if cough has returned and if so, how severe the
      cough is.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 22, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">September 30, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in cough severity</measure>
    <time_frame>Baseline, every two weeks (+/- 1 week) post-treatment (estimated 3 months total)</time_frame>
    <description>Patient will complete the Leicester Cough Questionnaire at each visit. This is a validated survey that measures 3 domains (physical, psychological and social). The total score range is 3-21 and domain scores range from 1-7; a higher score indicates a better quality of life.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective improvement in cough</measure>
    <time_frame>Every two weeks (+/- 1 week) post-treatment (estimated 3 months total), 3 months post completion of therapy</time_frame>
    <description>Patient will state dichotomously &quot;yes&quot; or &quot;no&quot; if cough overall improved at each visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily change in subjective cough severity</measure>
    <time_frame>Daily after each treatment (estimated 3 months total)</time_frame>
    <description>Patient will fill out a Visual Analogue Scale measuring cough severity. Patients will be given a log to complete daily after treatment completed and instructed to mark on a line with a &quot;X&quot; how severe the cough is. The far left of the line will indicate no cough at all, and the far right is indicative of the most severe cough.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Cough</condition>
  <condition>Superior Laryngeal Nerve Block</condition>
  <condition>Neurogenic Cough</condition>
  <arm_group>
    <arm_group_label>Steroid-Lidocaine Mixture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Will receive numbing injection, which is a mixture of steroid and lidocaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Will receive saline injection as a placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Superior laryngeal nerve block</intervention_name>
    <description>Injection of either the steroid-lidocaine mixture or placebo through the skin around where the superior laryngeal nerve is located on the neck. The procedure lasts 5 minutes and is done in the clinic.</description>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_label>Steroid-Lidocaine Mixture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Injection of placebo (saline)</intervention_name>
    <description>Superior laryngeal nerve block using 1mL of saline as the injection.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Injection of steroid-lidocaine mixture</intervention_name>
    <description>Superior laryngeal nerve block using 1mg 1:1 triamcinolone 40mg: 1% lidocaine with 1:200000 epinephrine as the injection.</description>
    <arm_group_label>Steroid-Lidocaine Mixture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  History consistent with neurogenic cough

          -  Exclusion of other etiologies (see exclusion criteria)

          -  Age â‰¥ 18

        Exclusion Criteria:

          -  Current neuromodulating medication use

          -  Untreated other etiologies of cough:

        Current smoker Current ACE/ARB use Abnormal PFTs within 6 months Uncontrolled OSA Abnormal
        CXR within 6 months RSI &gt; 13 or RFS &gt;11 AND workup positive for GERD (esophagram, 24-hour
        pH probe, manometry, EGD)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Courtney Tipton</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Courtney Tipton, MD</last_name>
    <phone>(843) 792-3531</phone>
    <email>tiptonc@musc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29403</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Tipton</last_name>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>June 4, 2020</study_first_submitted>
  <study_first_submitted_qc>June 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 9, 2020</study_first_posted>
  <last_update_submitted>July 27, 2020</last_update_submitted>
  <last_update_submitted_qc>July 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Courtney Tipton</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>superior laryngeal nerve block</keyword>
  <keyword>chronic cough</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cough</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

